This figure includes expenditures on both obesity-indicated GLP-1s and Type 2 diabetes-indicated GLP-1s prescribed to patients with an obesity diagnosis
Extended bioluminescence resonance energy transfer (eBRET) for monitoring prolonged protein-protein interactions in live cells
12 weeks 1-2 x 10 mL bottles Approx 8 mL retatrutide + 8 mL CJC/Ipa across the cycle
If you have a sensitive stomach, you can take them with a light snack
Youve probably heard buzz about some of these treatments for weight loss too, though theyre primarily for diabetes
Ghanim H, Abuaysheh S, Sia CL, Korzeniewski K, Chaudhuri A, Fernandez-Real JM, et al